Protected carotid stenting in high-risk patients: Results of the SpideRX arm of the carotid revascularization with ev3 arterial technology evolution trial

Journal of Interventional Cardiology

Volumn 23, Issue 5, 2010, Pages 491-498

  Safian, Robert D ^a   Jaff, Michael R ^b   Bresnahan, John F ^c   Foster, Malcolm ^d   Bacharach, J Michael ^e   Yadav, Jay ^f   Joye, James ^g   Myla, Subbarao ^h   Kassab, Elias ⁱ   Mann, J Tift ^j   Ansel, Gary M ^k  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Baptist Heart Institute   (United States)

^e Avera Heart Hospital of South Dakota   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g EL CAMINO HOSPITAL   (United States)

^h HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

ⁱ OAKWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^j Wake Heart Associates   (United States)

^k RIVERSIDE METHODIST HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTERY DIAMETER; ARTICLE; BRAIN HEMORRHAGE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CAROTID ENDARTERECTOMY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STENT THROMBOSIS; STROKE; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CAROTID ARTERIES; CAROTID STENOSIS; CONFIDENCE INTERVALS; FEASIBILITY STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; STENTS;

EID: 77957733656     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2010.00578.x     Document Type: Article

References (21)

1. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004 351 : 1493 1501.
2. Safian RD, Bacharach JM, Ansel GM, et al. Carotid stenting with a new system for distal embolic protection and stenting in high-risk patients: The Carotid Revascularization with ev3 Arterial Technology Evolution (CREATE) feasibility trial. Catheter Cardiovasc Interv 2004 63 : 1 6.
3. Summary of Safety and Effectiveness Data, Acculink Carotid Stent System and Rx Acculink Carotid Stent System, Guidant Corporation PMA #P040012, data on file with the FDA (August 30, 2004).
4. Summary of Safety and Effectiveness Data, Xact Carotid Stent System, Abbott Vascular Devices PMA# P040038, data on file with the FDA (September 6, 2005).
5. Data on File with the FDA.
6. Hobson RW II., Howard VJ, Roubin GS, et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 2004 30 : 1106 1111.
7. Hopkins LN, Myla S, Grube E, et al. Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ: 1-Year results in the CABERNET trial. Catheter Cardiovasc Interv 2008 71 : 950 960.
8. Gurm HS, Yadav JS, Fayad P, et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med 2008 358 : 1572 1579.
9. Gray WA, Yadav JS, Verta P, et al. The CAPTURE registry: Predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting. Catheter Cardiovasc Interv 2007 70 : 1025 1033.
10. Safian RD, Bresnahan JF, Jaff MR, et al. Protected carotid stenting in high-risk patients with severe carotid stenosis. J Am Coll Cardiol 2006 47 : 2384 2389.
11. Fairman R, Gray WA, Scicli AP, et al. The capture registry: Analysis of strokes resulting from carotid artery stenting in the post approval setting: Timing, location, severity, and type. Ann Surg 2007 246 : 551 558.
12. Lyer SS, White CJ, Jopkins LN, et al. Carotid artery revascularization in high-surgical risk patients using the carotid WALLSTENT and filter-wire EX/EL: 1-year outcomes in the BEACH Pivotal Group. J AM Coll Cardiol 2008 51 : 427 434.
13. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991 325 : 445 453.
14. Endarterectomy for moderate symptomatic carotid stenosis: Interim results from the MRC European Carotid Surgery Trial. Lancet 1996 347 : 1591 1593.
15. Endarterectomy for asymptomatic carotid artery stenosis: Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995 273 : 1421 1428.
16. Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomized controlled trial. Lancet 2004 363 : 1491 1502.
17. Mas JL, Chatellier G, Beyssen B et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Eng J Med 2006 355 : 1660 1671.
18. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomized non-inferiority trial. Lancet 2006 368 : 1239 1247.
19. Hobson RW. Crest (Carotid Revascularization Endarterectomy Versus Stent Trial): Background design, and current status. Semin Vasc Surg 2000 13 : 139 142.
20. http://www.clinicaltrials.gov/ct2/show/record/NCT00106938
21. Ouriel K, Hertzer NR, Beven EG, et al. Preprocedural risk stratification: Identifying an appropriate population for carotid stenting. J Vasc Surg 2001 33 : 728 732.